Lung cancers: molecular characterization, clonal heterogeneity and evolution, and cancer stem cells

U Testa, G Castelli, E Pelosi - Cancers, 2018 - mdpi.com
Lung cancer causes the largest number of cancer-related deaths in the world. Most (85%) of
lung cancers are classified as non-small-cell lung cancer (NSCLC) and small-cell lung …

HIF-1-independent mechanisms regulating metabolic adaptation in hypoxic cancer cells

SH Lee, M Golinska, JR Griffiths - Cells, 2021 - mdpi.com
In solid tumours, cancer cells exist within hypoxic microenvironments, and their metabolic
adaptation to this hypoxia is driven by HIF-1 transcription factor, which is overexpressed in a …

Lysine demethylase KDM6A in differentiation, development, and cancer

N Tran, A Broun, K Ge - Molecular and cellular biology, 2020 - Taylor & Francis
ABSTRACT Lysine demethylase 6A (KDM6A), also known as UTX, belongs to the KDM6
family of histone H3 lysine 27 (H3K27) demethylases, which also includes UTY and KDM6B …

The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism

S Chang, S Yim, H Park - Experimental & molecular medicine, 2019 - nature.com
Recent studies on mutations in cancer genomes have distinguished driver mutations from
passenger mutations, which occur as byproducts of cancer development. The cancer …

[HTML][HTML] Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer

X Tong, AS Patel, E Kim, H Li, Y Chen, S Li, S Liu… - Cancer Cell, 2024 - cell.com
Summary KRAS G12C inhibitors (adagrasib and sotorasib) have shown clinical promise in
targeting KRAS G12C-mutated lung cancers; however, most patients eventually develop …

UTX mutations in human cancer

L Wang, A Shilatifard - Cancer cell, 2019 - cell.com
Ubiquitously transcribed tetratricopeptide repeat on chromosome X (UTX, encoded by
KDM6A) is a histone demethylase that targets di-and tri-methylated histone H3 lysine 27 …

Selective activator of human ClpP triggers cell cycle arrest to inhibit lung squamous cell carcinoma

LL Zhou, T Zhang, Y Xue, C Yue, Y Pan… - Nature …, 2023 - nature.com
Chemo-activation of mitochondrial ClpP exhibits promising anticancer properties. However,
we are currently unaware of any studies using selective and potent ClpP activators in lung …

JMJD family proteins in cancer and inflammation

W Manni, X Jianxin, H Weiqi, C Siyuan… - Signal transduction and …, 2022 - nature.com
The occurrence of cancer entails a series of genetic mutations that favor uncontrollable
tumor growth. It is believed that various factors collectively contribute to cancer, and there is …

Histone modification in NSCLC: molecular mechanisms and therapeutic targets

K Bajbouj, A Al-Ali, RK Ramakrishnan… - International journal of …, 2021 - mdpi.com
Lung cancer is the leading cause of cancer mortality in both genders, with non-small cell
lung cancer (NSCLC) accounting for about 85% of all lung cancers. At the time of diagnosis …

Histone lysine demethylases and their functions in cancer

J Sterling, SV Menezes, RH Abbassi… - International Journal of …, 2021 - Wiley Online Library
Histone lysine demethylases (KDMs) are enzymes that remove the methylation marks on
lysines in nucleosomes' histone tails. These changes in methylation marks regulate gene …